- Reviews (0)
Artheget Ez 80 Plus Tablet
Artheget Ez 80 plus Tablet, Artemether and lumefantrine combination is a fixed dose artemisinin-based combination therapy (ACT) combining artemether, an artemisinin derivative, and lumefantrine, a synthetic antimalarial drug. Artheget Ez 80plus480mg Tablet, a sesquiterpene lactone derivative of naturally occurring substance, artemisinin.
Chemically Artheget Ez 80 plus Tablet is (3R, 5aS, 6R, 8aS, 9R, 10S, 12R, 12aR)-Decahydro-10-methoxy-3,6,9-trimethyl-3,12-epoxy-12Hpyrano[4,3-j]1,2-benzodioxepin.
Ez 80 plus 480 mg Tablet is used for the treatment of malaria (intermittent or remittent diseases characterized by attacks of chills, fever, and sweating and caused by a parasitic protozoan transferred to the human bloodstream by an anopheles mosquito) in combination with other anti-malarial drugs resistant to conventional drugs.
Patients using this medication may at times experience abdominal pain, anorexia (eating disorder), diarrhea, vomiting, nausea, and dizziness. If you experience any of these symptoms for a long period of time, consult your doctor immediately.
You will need to make sure you have enough tablets to complete your full course of therapy.
Low levels of potassium or magnesium in the blood may also increase your risk Artheget Ez 80plus480mg Tablet is not recommended for use in patients with a known allergy to artemether, lumefantrine, any other artemisinin derivatives, or any other ingredients present in the formulation.
Artheget Ez 80plus480mg Tablet is used in the treatment of malaria.
- Abdominal pain and cramps
- Nausea and Vomiting
- Itching and skin rash
- Hives and wheezing severe
- Dizziness and lightheadedness
- Ringing or buzzing in the ears
- Increased heartbeat severe
- Elevated liver enzymes severe
- Muscle and joint pain
- Sleep disturbances
- Weight loss severe
- Shaking and trembling of arms and feet
- Decrease/loss of hearing severe
- Uncontrolled eye movements
When not to use Allergy
Artheget Ez 80plus480mg Tablet is not recommended for use in patients with a known allergy to artemether, lumefantrine, any other artemisinin derivatives, or any other ingredients present in the formulation.